Skip to main content
SP5007,796.70+0.62%DOW53,763.95-0.01%NASDAQ26,802.38+0.80%BTC$63,112.00-0.57%ETH$1,875.52-0.65%GOLD$4,429.80-0.84%OIL$82.00-1.53%
Smart Investors Daily
Sign InSign Up Free
AR

OTC · ARGQ

Argentum 47, Inc.

Financial Services · Insurance - Brokers

$0.02

Down-$0.01 (-35.48%)

Updated Aug 13, 2026, 5:21 PM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
117.85K
P/E ratio
-23.24
Dividend yield
0.00%
52-week range
$0.01 – $0.01
Volume
19.34K
Avg. volume
10.98K

Price performance

ARGQ price history

1M range · 0 trading sessions · Daily adjusted prices

ARGQ does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest ARGQ news

The latest Smart Investors Daily articles mentioning ARGQ.

Stock researchCompany · Overview

ARGQ research

Overview

Company profile and research snapshot.

Company profile

ARGENTUM 47 INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Jan 21, 2025

Argentum 47, Inc. Announces Acquisition of Marelius Biopharma Group, Divestiture of Argentum Data Solutions, and Leadership Transition

Argentum 47, Inc. has acquired Marelius Biopharma Group, a UK-based company specializing in training and educational services for the biopharmaceutical and pharmaceutical sectors. Argentum has also divested Argentum Data Solutions and appointed a new CEO, Sean Nathan Lloyd, to lead the company's next phase of growth and transformation.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By